Teligent Inc (NASDAQ:TLGT) gapped up prior to trading on Friday . The stock had previously closed at $1.46, but opened at $1.46. Teligent shares last traded at $1.30, with a volume of 9559 shares.

Separately, ValuEngine cut shares of Teligent from a “hold” rating to a “sell” rating in a research report on Tuesday, December 11th.

The company has a current ratio of 1.31, a quick ratio of 0.86 and a debt-to-equity ratio of 3.30. The stock has a market capitalization of $78.51 million, a P/E ratio of -7.37 and a beta of 1.59.

A number of institutional investors have recently modified their holdings of TLGT. Geode Capital Management LLC raised its holdings in Teligent by 3.9% during the 4th quarter. Geode Capital Management LLC now owns 479,485 shares of the company’s stock worth $656,000 after buying an additional 17,951 shares during the period. Millennium Management LLC acquired a new stake in Teligent during the 4th quarter worth about $39,000. Paloma Partners Management Co acquired a new stake in Teligent during the 4th quarter worth about $40,000. D. E. Shaw & Co. Inc. raised its holdings in Teligent by 27.1% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 203,729 shares of the company’s stock worth $279,000 after buying an additional 43,414 shares during the period. Finally, Prosight Management LP raised its holdings in Teligent by 9.5% during the 4th quarter. Prosight Management LP now owns 3,547,607 shares of the company’s stock worth $4,860,000 after buying an additional 306,846 shares during the period. Hedge funds and other institutional investors own 64.73% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Teligent (TLGT) Shares Gap Up to $1.46” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://theolympiareport.com/2019/03/17/teligent-tlgt-shares-gap-up-to-1-46.html.

Teligent Company Profile (NASDAQ:TLGT)

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Read More: Is the QQQ ETF safe?

Receive News & Ratings for Teligent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent and related companies with MarketBeat.com's FREE daily email newsletter.